BRADLEY SAENGER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BRADLEY SAENGER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BRADLEY SAENGER. BRADLEY SAENGER is Chief Financial Officer in Tonix Pharmaceuticals Holding Corp. ($TNXP).
Latest Insider Trading Transactions of BRADLEY SAENGER
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 25 2021 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 1.53 | 540,000 | 826,200 | 540,000 | |
Feb 25 2021 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 1.22 | 540,000 | 658,800 | 540,000 | |
May 06 2020 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 0.96 | 360,000 | 345,600 | 360,000 | |
May 06 2020 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 0.77 | 360,000 | 277,200 | 360,000 | |
Feb 27 2020 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 0.50 | 24,000 | 12,000 | 24,000 | |
Feb 27 2020 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 0.40 | 24,000 | 9,600 | 24,000 | |
May 08 2019 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 2.56 | 28,835 | 73,818 | 28,835 | |
May 08 2019 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 2.05 | 28,835 | 59,112 | 28,835 | |
Feb 27 2019 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 2.36 | 5,170 | 12,201 | 5,170 | |
Feb 27 2019 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 1.89 | 5,170 | 9,771 | 5,170 | |
Jun 14 2018 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Buy | P | 4.10 | 300 | 1,230 | 3,079 | 2.8 K to 3.1 K (+10.80 %) |
Feb 15 2018 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 4.25 | 39,150 | 166,388 | 39,150 | |
Feb 15 2018 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 3.40 | 39,150 | 133,110 | 39,150 | |
Mar 01 2017 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 0.55 | 47,500 | 26,125 | 47,500 | |
Mar 01 2017 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 0.55 | 47,500 | 26,125 | 47,500 | |
Jun 21 2016 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Buy | P | 2.00 | 2,000 | 4,000 | 6,039 | 4 K to 6 K (+49.52 %) |
May 31 2016 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 2.42 | 60,000 | 145,200 | 60,000 | |
May 31 2016 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 2.42 | 20,000 | 48,400 | 20,000 |
Page: 1